INTERNATIONAL MYELOMA FOUNDATION 2009 BRIAN D. NOVIS RESEARCH AWARD Senior GrantProvided by donations from private individuals The International Myeloma Foundation funds several research grants including the Brian D. Novis Research Award. These grants are provided through donations from private individuals, and are presented annually by the International Myeloma Foundation. These awards go to doctors/researchers doing work in the field of multiple myeloma. This year’s awards will be in the amount of $80,000. The Brian D. Novis Award honors the IMF’s founder Brian Novis, who died of multiple myeloma in July of 1992. The International Myeloma Foundation is a non-profit organization whose mission is to improve the quality of life for myeloma patients while working toward prevention and a cure.
QUALIFICATIONS These awards are targeted to established investigators with a track record in myeloma or related research, and are designed for projects which represent a different focus, direction or area of research from those in which they are currently funded. In most cases, these awards will be for pilot projects to obtain sufficient funding for larger applications from NIH or similar larger funding agencies. The qualifications for a candidate for the Brian D. Novis Senior Research Award include the following: · Ability to provide a completed application with evidence of a meritorious research project. · Must complete and return application package to the IMF no later than Tuesday, September 2nd.
International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607-3421 USA phone: 800-452-2873 (US and Canada) 818-487-7455 (elsewhere) fax: 818-487-7454 email: TheIMF@myeloma.org
INTERNATIONAL MYELOMA FOUNDATION 2009 Brian D. Novis Research Award Junior Grant Provided by donations from private individuals
Deadline: on or before September 2nd, 2008. The International Myeloma Foundation funds several research grants including the Brian D. Novis Research Award. These grants are provided through donations from private individuals, and are presented annually by the International Myeloma Foundation. These awards go to doctors/researchers doing work in the field of multiple myeloma. This year's awards will be in the amount of $50,000. The Brian D. Novis Award honors the IMF’s founder Brian Novis, who died of multiple myeloma in July of 1992. The International Myeloma Foundation is a non-profit organization whose mission is to improve the quality of life for myeloma patients while working toward prevention and a cure.
QUALIFICATIONS The qualifications for a candidate for the Brian D. Novis Research Award include the following: · Completed postdoctoral studies or clinical fellowships not later than August 1 of the application year. · Ability to devote a minimum of 50% of his or her time to the research project during the Award year. · Ability to provide a completed application with evidence of a meritorious research project. · Must complete and return application package to the IMF no later than September 2, 2008.
Institute for Neuroacanthocytosis Research Grants We encourage applications for research grants for investigations into the genetics, diagnostics and epidemiology of the NA syndromes as well as the pathophysiology and the related red blood cell abnormalities. Neuroacanthocytosis syndromes are a group of rare diseases, characterised by misshaped erythrocytes and progressive neurodegeneration, causing movement disorders and neuropsychiatric symptoms. The rarity and wide geographical spread of the NA diseases have contributed to a number of different researchers principally in Europe and Japan pursuing specific studies of the elements of the NA phenotypes including descriptive history of the development of the disease, the abnormalities of the erthrocytes and the function of the VPS 13A protein that is absent in chorea-acanthocytosis. Since acanthocytosis is part of the NA syndromes clinical manifestations, the study of acanthocytes may offer the possibility to progress in the disease’ knowledge, to identify new cell signalling pathways towards either membrane proteins or transport systems.
Our Objectives for Research To pursue the fundamental physiological questions raised by NA including the: role of the proteins affected by the mutated genes in each disease as well as their molecular and cellular function cause and significance of the spiky red blood cell membranes that are a defining characteristic of the diseases pathway that leads to neuronal apoptosis in each of the diseases To promote wide collaboration in the clinical study of the diseases. Because no country has more than an estimated 100 cases of NA and most countries in the world have fewer than 10 cases, it is vital that case histories of patients from around the world be available to those studying the clinical aspects of the diseases. To develop the tools and the skill of neurologists to diagnose and, in the future, to treat the diseases. To collaborate effectively with research into other similar conditions especially Huntington’s disease. To encourage new, promising projects with seed money and assist in approaching larger grantors.
Our Values Our funding seeks to: Promote basic, curiosity-driven, investigator–led research that relates to the phenotypes of the NA diseases. Bring together the wide research community around the world including haematology, cell biology, neuroscience and neuropsychiatry. Encourage the wide dissemination of and free access to the research we support. We will seek to support unrestricted access and the public benefit wherever possible by requiring electronic copies of any research papers that have been accepted for publication in a peer-reviewed journal and are supported by the Advocacy to be deposited into PubMed Central (PMC) to be made freely available as soon as possible and in any event within six months of the journal publisher’s official date of final publication. Do every thing possible to have strong communication with researchers receiving grants to assure that funds are used for the intended purpose. Promote good communications between those working on NA research and others concerned with other diseases of the basal ganglia.
Guidelines for Applying for an Unrestricted GrantThe CSL Behring Foundation for Research and Advancement of Patient Health offers a type of grant designed to assist small, community-based organizations in delivering their many valuable services to the communities they serve.The CSL Behring Foundation intends to award up to five $10,000 unrestricted grants per year (applications will only be accepted during the second grant cycle each year). Grants in this category will be evaluated on their merits, non-competitively with other applicants.To apply and qualify, patient organizations MUST meet the following criteria: * Be a recognized patient organization for persons with bleeding disorders * Have an annual operating budget of less than $100,000 * Provide payment for staff services to two or less people * Have obtained 501(c)(3) tax status * Have not received unrestricted grant support from the CSL Behring Foundation previously
How to ApplyTo apply for an unrestricted grant, please use the unrestricted grant application form.To apply, submit a brief statement of how the funds would be used. The proposed use of the funds could be as simple as helping to fund ongoing operations, securing or upgrading office equipment, or seed money for starting a new program.If more than five applications are received and deemed eligible, lots would be drawn to select winners.In order to apply for this grant, please apply using the unrestricted grant application and email to CB.Foundation@cslbehring.com. Unrestricted grant requests are reviewed annually only. Proposals for unrestricted grants must be received by the CSL Behring Foundation no later than July 31st, 2008. Unrestricted grant awards will be announced in October 2008.
For guidance and suggestions on writing a compelling grant proposal, please visit the CSL Behring Foundation website at www.cslbehringfoundation.com and review the “Grant Writing Guidelines” section.
12next